You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Optimizing Care for Patients With NF1-Associated Tumors: Leveraging the Multidisciplinary Team

  • Authors: Matthias A. Karajannis, MD, MS; Alyssa Reddy, MD; Ori Barzilai, MD
  • CME / ABIM MOC Released: 11/23/2022
  • Valid for credit through: 11/23/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 1.00 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for pediatricians, oncologists (including pediatric oncologists), neurologists, surgeons, and other healthcare providers involved in the care of patients with NF1.

The goal of this activity is that learners will be better able to understand the role of the multidisciplinary team in the optimal management of pediatric patients with NF1-associated tumors.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical characteristics of NF1
    • Surgical management of NF1-associated tumors
    • Systemic therapies used to manage pediatric patients with NF1-associated tumors
  • Have greater competence related to
    • Tailoring treatment decisions for pediatric patients with NF1-associated tumors
  • Demonstrate greater confidence in their ability to
    • Build a collaborative practice to optimize care for pediatric patients with NF1-associated tumors


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Moderator

  • Matthias A. Karajannis, MD, MS

    Professor of Pediatrics 
    Weill Cornell Medical College 
    Chief, Pediatric Neuro-Oncology Service 
    Department of Pediatrics 
    Memorial Sloan Kettering Cancer Center  
    New York, New York 

    Disclosures

    Matthias A. Karajannis, MD, MS, has the following relevant financial relationships:
    Consultant or advisor for: Cardinal Health; CereXis; QED Therapeutics; Recursion
    Research funding from: Y-mAbs
    Owns stock (publicly traded) in: 3M

Panelists

  • Alyssa Reddy, MD

    Professor of Neurology
    UCSF Weill Institute for Neurosciences
    Director, UCSF Neurofibromatosis Program
    San Francisco, California

    Disclosures

    Alyssa Reddy, MD, has the following relevant financial relationships:
    Consultant or advisor for: AstraZeneca/Alexion; Novartis

  • Ori Barzilai, MD

    Director of Minimally Invasive Spine Oncology 
    Department of Neurosurgery 
    Memorial Sloan Kettering Cancer Center 
    New York, New York 

    Disclosures

    Ori Barzilai, MD, has no relevant financial relationships.

Editor

  • John Churchwell, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    John Churchwell, PhD, has the following relevant financial relationships:
    Employed by an ineligible company: Medtronic (former)

Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Optimizing Care for Patients With NF1-Associated Tumors: Leveraging the Multidisciplinary Team

Authors: Matthias A. Karajannis, MD, MS; Alyssa Reddy, MD; Ori Barzilai, MDFaculty and Disclosures

CME / ABIM MOC Released: 11/23/2022

Valid for credit through: 11/23/2023

processing....

Educational Impact Challenge

The goal of this activity is that learners will be better able to understand the role of the multidisciplinary team in the optimal management of pediatric patients with NF1-associated tumors.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.